U.S. Baby Infant Formula Market by Product Type (Infant Milk, Follow-on Milk, Specialty Baby Milk, and Growing-up Milk), Ingredient (Carbohydrate, Fat, Protein, Minerals, Vitamins, and Others), Distribution Channel (Hypermarkets, Supermarkets, Pharmacy/Medical Stores, Specialty Stores, Hard Discounter Stores, and Others), and Point of Sale (Prescription Based and OTC): Opportunity Analysis and Industry Forecast 2021–2027
The U.S. baby infant formula market was valued at $3,653 million in 2019, and is projected to reach $5,811 million by 2027, registering a CAGR of 5.8% from 2021 to 2027.
Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.
Increase in participation of women in labor force in the U.S., acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population has increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and growth of the middle-class population have led to changes in the lifestyle. The middle-class population is more affluent and can afford to spend more on their children, thus driving the market growth. In addition, consumer perception of high nutritional content in the infant formula supplements the market growth. Furthermore, increase in health consciousness among consumers is boosting the demand for infant formula having high content of protein, minerals, and vitamins. However, concerns related to food safety and decline in birth rate are anticipated to hamper the market growth. On the contrary, shift in preference for organic infant formulas is expected to offer new avenues for the manufacturers.
The U.S. baby infant formula market is segmented into type, ingredient, and distribution channel. Depending on type, the market is segregated into infant milk, follow-on-milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrate, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others.
The players operating in the U.S. baby infant formula market have adopted various developmental strategies to expand their market share, exploit the U.S. baby infant formula market opportunity, and increase profitability in the market. The key players profiled in this report include Abbott Laboratories, Arla Foods, Bobbie, Campbell Soups Company, Dana Dairy Group, Ltd., Danone S.A., D-Signstore, Else Nutrition Holdings, Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC., Nestle S.A., Reckitt Benckiser Group Plc., and The Hain Celestial Group, Inc.
Key benefits for the stakeholder
Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.
Increase in participation of women in labor force in the U.S., acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population has increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and growth of the middle-class population have led to changes in the lifestyle. The middle-class population is more affluent and can afford to spend more on their children, thus driving the market growth. In addition, consumer perception of high nutritional content in the infant formula supplements the market growth. Furthermore, increase in health consciousness among consumers is boosting the demand for infant formula having high content of protein, minerals, and vitamins. However, concerns related to food safety and decline in birth rate are anticipated to hamper the market growth. On the contrary, shift in preference for organic infant formulas is expected to offer new avenues for the manufacturers.
The U.S. baby infant formula market is segmented into type, ingredient, and distribution channel. Depending on type, the market is segregated into infant milk, follow-on-milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrate, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others.
The players operating in the U.S. baby infant formula market have adopted various developmental strategies to expand their market share, exploit the U.S. baby infant formula market opportunity, and increase profitability in the market. The key players profiled in this report include Abbott Laboratories, Arla Foods, Bobbie, Campbell Soups Company, Dana Dairy Group, Ltd., Danone S.A., D-Signstore, Else Nutrition Holdings, Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC., Nestle S.A., Reckitt Benckiser Group Plc., and The Hain Celestial Group, Inc.
Key benefits for the stakeholder
- The report provides an in-depth analysis of the current trends, drivers, and dynamics of the U.S. baby infant formula market to elucidate the prevailing opportunities and potential investment pockets.
- It offers qualitative trends and quantitative analysis for the period of 2019–2027 to assist stakeholders to understand the market scenario.
- In-depth analysis of the key segments demonstrates the trending types across the U.S.
- Competitive intelligence of the industry highlights the business practices followed by key players across U.S. and the prevailing market opportunities.
- The key players are profiled along with their strategies and developments to understand the competitive outlook of the industry.
- By Product Type
- Infant milk
- Follow-on milk
- Specialty baby milk
- Growing-up milk
- By Ingredient
- Carbohydrate
- Fat
- Protein
- Minerals
- Vitamins
- Others
- By Distribution channel
- Hypermarkets
- Supermarkets
- Pharmacy/medical stores
- Specialty stores
- Hard discounter stores
- Others
- By Product Type
- Prescription based
- OTC
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for the stakeholder
1.3.Key market segments
1.4.Research methodology
1.4.1.Primary Research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key finding of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five force analysis
3.3.1.Bargaining power of suppliers
3.3.2.Bargaining power of buyers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Intensity of competitive rivalry
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in number of women participation in labor force
3.4.1.2.High nutritional content of infant formula
3.4.2.Restraint
3.4.2.1.Concerns related to food safety
3.4.2.2.Government initiatives to promote breastfeeding
3.4.3.Opportunity
3.4.3.1.Shift in preference toward organic baby food & drinks
3.4.3.2.Developments in technology result in emergence of new products
3.4.3.3.Extensive research on prebiotic and probiotics in baby food
3.5.Value chain analysis
3.6.Impact of key regulation
3.7.U.S. Baby Infant Formula Market: COVID-19 Impact Analysis
CHAPTER 4:U.S. BABY INFANT FORMULA MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Infant milk
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.Follow-on milk
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.4.Specialty baby milk
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market size and forecast
4.5.Growing-up milk
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
CHAPTER 5:U.S. BABY INFANT FORMULA MARKET, BY INGRIDIENT
5.1.Overview
5.1.1.Market size and forecast
5.2.Carbohydrate
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.3.Fat
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.4.Protein
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.5.Minerals
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast
5.6.Vitamins
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast
5.7.Others
5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast
CHAPTER 6:U.S. BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Hypermarkets
'6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.3.Supermarkets
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.4.Pharmacy/medical stores
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.5.Specialty stores
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.6.Hard discounter stores
6.6.1.Key market trends, growth factors, and opportunities
6.6.2.Market size and forecast
6.7.Others
6.7.1.Key market trends, growth factors, and opportunities
6.7.2.Market size and forecast
CHAPTER 7:COMPETITION LANDSCAPE
7.1.Top winning strategies
7.2.Product mapping
7.3.Competitive dashboard
7.4.Competitive heat map
7.5.Brand positioning analysis
7.6.Key developments
7.6.1.Acquisition
7.6.2.Agreement
7.6.3.Product launch
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company snapshot
8.1.2.Operating business segments
8.1.3.Product portfolio
8.1.4.Distribution channel
8.1.5.R&D expenditure
8.1.6.Business performance
8.2.ARLA FOODS AMBA
8.2.1.Company snapshot
8.2.2.Operating business segments
8.2.3.Product portfolio
8.2.4.Distribution channel
8.2.5.R&D expenditure
8.2.6.Business performance
8.2.7.Key strategic moves and developments
8.3.BOBBIE
8.3.1.Company snapshot
8.3.2.Product portfolio
8.3.3.Distribution channel
8.3.4.Key strategic moves and developments
8.4.CAMPBELL SOUPS COMPANY
8.4.1.Company snapshot
8.4.2.Operating business segments
8.4.3.Product portfolio
8.4.4.Distribution channel
8.4.5.R&D expenditure
8.4.6.Business performance
8.5.DANA DAIRY GROUP LTD.
8.5.1.Company snapshot
8.5.2.Product portfolio
8.5.3.Distribution channel
8.5.4.Key strategic moves and developments
8.6.DANONE SA
8.6.1.Company snapshot
8.6.2.Operating business segments
8.6.3.Product portfolio
8.6.4.Distribution channel
8.6.5.Business performance
8.7.D-SIGNSTORE
8.7.1.Company snapshot
8.7.2.Product portfolio
8.7.3.Distribution channel
8.8.ELSE NUTRITION HOLDINGS INC
8.8.1.Company snapshot
8.8.2.Product portfolio
8.8.3.Distribution channel
8.8.4.Key strategic moves and developments
8.9.HIPP GMBH & CO. VERTRIEB KG
8.9.1.Company snapshot
8.9.2.Product portfolio
8.9.3.Distribution channel
8.10.HOLLE BABY FOOD AG
8.10.1.Company snapshot
8.10.2.Product portfolio
8.10.3.Distribution channel
8.11.KABRITA USA
8.11.1.Company snapshot
8.11.2.Product portfolio
8.11.3.Distribution channel
8.12.NATURE’S ONE, LLC
8.12.1.Company snapshot
8.12.2.Product portfolio
8.12.3.Distribution channel
8.12.4.Key strategic moves and developments
8.13.NESTLE S.A.
8.13.1.Company snapshot
8.13.2.Operating business segments
8.13.3.Product portfolio
8.13.4.Distribution channel
8.13.5.Business performance
8.13.6.Key strategic moves and developments
8.14.RECKITT BENCKISER GROUP PLC
8.14.1.Company snapshot
8.14.2.Operating business segments
8.14.3.Product portfolio
8.14.4.Distribution channel
8.14.5.R&D expenditure
8.14.6.Business performance
8.15.THE HAIN CELESTIAL GROUP, INC.
8.15.1.Company snapshot
8.15.2.Product portfolio
8.15.3.Distribution channel
8.15.4.Business performance
1.1.Report description
1.2.Key benefits for the stakeholder
1.3.Key market segments
1.4.Research methodology
1.4.1.Primary Research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key finding of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five force analysis
3.3.1.Bargaining power of suppliers
3.3.2.Bargaining power of buyers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Intensity of competitive rivalry
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in number of women participation in labor force
3.4.1.2.High nutritional content of infant formula
3.4.2.Restraint
3.4.2.1.Concerns related to food safety
3.4.2.2.Government initiatives to promote breastfeeding
3.4.3.Opportunity
3.4.3.1.Shift in preference toward organic baby food & drinks
3.4.3.2.Developments in technology result in emergence of new products
3.4.3.3.Extensive research on prebiotic and probiotics in baby food
3.5.Value chain analysis
3.6.Impact of key regulation
3.7.U.S. Baby Infant Formula Market: COVID-19 Impact Analysis
CHAPTER 4:U.S. BABY INFANT FORMULA MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Infant milk
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.Follow-on milk
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.4.Specialty baby milk
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market size and forecast
4.5.Growing-up milk
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
CHAPTER 5:U.S. BABY INFANT FORMULA MARKET, BY INGRIDIENT
5.1.Overview
5.1.1.Market size and forecast
5.2.Carbohydrate
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.3.Fat
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.4.Protein
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.5.Minerals
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast
5.6.Vitamins
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast
5.7.Others
5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast
CHAPTER 6:U.S. BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Hypermarkets
'6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.3.Supermarkets
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.4.Pharmacy/medical stores
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.5.Specialty stores
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.6.Hard discounter stores
6.6.1.Key market trends, growth factors, and opportunities
6.6.2.Market size and forecast
6.7.Others
6.7.1.Key market trends, growth factors, and opportunities
6.7.2.Market size and forecast
CHAPTER 7:COMPETITION LANDSCAPE
7.1.Top winning strategies
7.2.Product mapping
7.3.Competitive dashboard
7.4.Competitive heat map
7.5.Brand positioning analysis
7.6.Key developments
7.6.1.Acquisition
7.6.2.Agreement
7.6.3.Product launch
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company snapshot
8.1.2.Operating business segments
8.1.3.Product portfolio
8.1.4.Distribution channel
8.1.5.R&D expenditure
8.1.6.Business performance
8.2.ARLA FOODS AMBA
8.2.1.Company snapshot
8.2.2.Operating business segments
8.2.3.Product portfolio
8.2.4.Distribution channel
8.2.5.R&D expenditure
8.2.6.Business performance
8.2.7.Key strategic moves and developments
8.3.BOBBIE
8.3.1.Company snapshot
8.3.2.Product portfolio
8.3.3.Distribution channel
8.3.4.Key strategic moves and developments
8.4.CAMPBELL SOUPS COMPANY
8.4.1.Company snapshot
8.4.2.Operating business segments
8.4.3.Product portfolio
8.4.4.Distribution channel
8.4.5.R&D expenditure
8.4.6.Business performance
8.5.DANA DAIRY GROUP LTD.
8.5.1.Company snapshot
8.5.2.Product portfolio
8.5.3.Distribution channel
8.5.4.Key strategic moves and developments
8.6.DANONE SA
8.6.1.Company snapshot
8.6.2.Operating business segments
8.6.3.Product portfolio
8.6.4.Distribution channel
8.6.5.Business performance
8.7.D-SIGNSTORE
8.7.1.Company snapshot
8.7.2.Product portfolio
8.7.3.Distribution channel
8.8.ELSE NUTRITION HOLDINGS INC
8.8.1.Company snapshot
8.8.2.Product portfolio
8.8.3.Distribution channel
8.8.4.Key strategic moves and developments
8.9.HIPP GMBH & CO. VERTRIEB KG
8.9.1.Company snapshot
8.9.2.Product portfolio
8.9.3.Distribution channel
8.10.HOLLE BABY FOOD AG
8.10.1.Company snapshot
8.10.2.Product portfolio
8.10.3.Distribution channel
8.11.KABRITA USA
8.11.1.Company snapshot
8.11.2.Product portfolio
8.11.3.Distribution channel
8.12.NATURE’S ONE, LLC
8.12.1.Company snapshot
8.12.2.Product portfolio
8.12.3.Distribution channel
8.12.4.Key strategic moves and developments
8.13.NESTLE S.A.
8.13.1.Company snapshot
8.13.2.Operating business segments
8.13.3.Product portfolio
8.13.4.Distribution channel
8.13.5.Business performance
8.13.6.Key strategic moves and developments
8.14.RECKITT BENCKISER GROUP PLC
8.14.1.Company snapshot
8.14.2.Operating business segments
8.14.3.Product portfolio
8.14.4.Distribution channel
8.14.5.R&D expenditure
8.14.6.Business performance
8.15.THE HAIN CELESTIAL GROUP, INC.
8.15.1.Company snapshot
8.15.2.Product portfolio
8.15.3.Distribution channel
8.15.4.Business performance
LIST OF TABLES
TABLE 01.U.S. BABY INFANT FORMULA MARKET VALUE, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 02.U.S. BABY INFANT FORMULA MARKET VOLUME, BY PRODUCT TYPE, 2019–2027 (KILOTON)
TABLE 03.U.S. BABY INFANT MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 04.U.S. BABY INFANT MILK MARKET VOLUME, 2019–2027 (KILOTON)
TABLE 05.U.S. FOLLOW-ON MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 06.U.S. FOLLOW-ON MILK MARKET VOLUME , 2019–2027 (KILOTON)
TABLE 07.U.S. SPECIALTY BABY MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 08.U.S. SPECIALTY BABY MILK MARKET VOLUME, 2019–2027 (KILOTON)
TABLE 09.U.S. BABY INFANT FORMULA MARKET VALUE, BY POINT OF SALE, 2019–2027 ($MILLION)
TABLE 10.U.S. GROWING-UP MILK MARKET VALUE , 2019–2027 ($MILLION)
TABLE 11.U.S. GROWING-UP MILK MARKET VOLUME , 2019–2027 (KILOTON)
TABLE 12.U.S. BABY INFANT FORMULA MARKET VALUE, BY INGREDIENT, 2019–2027 ($MILLION)
TABLE 13.U.S. BABY INFANT FORMULA MARKET VALUE FOR CARBOHYDRATE, 2019–2027 ($MILLION)
TABLE 14.U.S. BABY INFANT FORMULA MARKET VALUE FOR FAT, 2019–2027 ($MILLION)
TABLE 15.U.S. BABY INFANT FORMULA MARKET VALUE FOR PROTEIN, 2019–2027 ($MILLION)
TABLE 16.U.S. BABY INFANT FORMULA MARKET VALUE FOR MINERALS, 2019–2027 ($MILLION)
TABLE 17.U.S. BABY INFANT FORMULA MARKET VALUE FOR VITAMINS, 2019–2027 ($MILLION)
TABLE 18.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2019–2027 ($MILLION)
TABLE 19.U.S. BABY INFANT FORMULA MARKET VALUE, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 20.U.S. BABY INFANT FORMULA MARKET VALUE FOR HYPERMARKET, 2019–2027 ($MILLION)
TABLE 21.U.S. BABY INFANT FORMULA MARKET VALUE FOR SUPERMARKET, 2019–2027 ($MILLION)
TABLE 22.U.S. BABY INFANT FORMULA MARKET VALUE FOR PHARMACY/MEDICAL STORES, 2019–2027 ($MILLION)
TABLE 23.U.S. BABY INFANT FORMULA MARKET VALUE FOR SPECIALTY STORES, 2019–2027 ($MILLION)
TABLE 24.U.S. BABY INFANT FORMULA MARKET VALUE FOR HARD DISCOUNTER STORES, 2019–2027 ($MILLION)
TABLE 25.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2019–2027 ($MILLION)
TABLE 26.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 27.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 28.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 29.ABBOTT LABORATORIES: DISTRIBUTION CHANNEL
TABLE 30.ABBOTT LABORATORIES: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 31.ABBOTT LABORATORIES: NET SALES, 2017–2019 ($MILLION)
TABLE 32.ARLA FOODS AMBA: COMPANY SNAPSHOT
TABLE 33.ARLA FOODS AMBA: OPERATING SEGMENTS
TABLE 34.ARLA FOODS AMBA: PRODUCT PORTFOLIO
TABLE 35.ARLA FOODS AMBA: DISTRIBUTION CHANNEL
TABLE 36.ARLA FOODS AMBA: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 37.ARLA FOODS: NET SALES, 2017–2019 ($MILLION)
TABLE 38.BOBBIE: COMPANY SNAPSHOT
TABLE 39.BOBBIE: PRODUCT PORTFOLIO
TABLE 40.BOBBIE: DISTRIBUTION CHANNEL
TABLE 41.CAMPBELL SOUP COMPANY: COMPANY SNAPSHOT
TABLE 42.CAMPBELL SOUP COMPANY: OPERATING SEGMENTS
TABLE 43.CAMPBELL SOUP COMPANY: PRODUCT PORTFOLIO
TABLE 44.CAMPBELL SOUP COMPANY: DISTRIBUTION CHANNEL
TABLE 45.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 46.CAMPBELL SOUP COMPANY: NET SALES, 2017–2019 ($MILLION)
TABLE 47.DANA DAIRY GROUP LTD.: COMPANY SNAPSHOT
TABLE 48.DANA DAIRY GROUP LTD: PRODUCT PORTFOLIO
TABLE 49.DANA DAIRY GROUP LTD: DISTRIBUTION CHANNEL
TABLE 50.DANONE SA: COMPANY SNAPSHOT
TABLE 51.DANONE SA: OPERATING SEGMENTS
TABLE 52.DANONE SA: PRODUCT PORTFOLIO
TABLE 53.DANONE SA: DISTRIBUTION CHANNEL
TABLE 54.DANONE SA: NET SALES, 2017–2019 ($MILLION)
TABLE 55.D-SIGNSTORE: COMPANY SNAPSHOT
TABLE 56.D-SIGNSTORE: PRODUCT PORTFOLIO
TABLE 57.D-SIGNSTORE: DISTRIBUTION CHANNEL
TABLE 58.ELSE NUTRITION HOLDINGS INC: COMPANY SNAPSHOT
TABLE 59.ELSE NUTRITION HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 60.ELSE NUTRITION HOLDINGS INC: DISTRIBUTION CHANNEL
TABLE 61.HIPP GMBH & CO. VERTRIEB KG: COMPANY SNAPSHOT
TABLE 62.HIPP GMBH & CO. VERTRIEB KG: PRODUCT PORTFOLIO
TABLE 63.HIPP GMBH & CO. VERTRIEB KG: DISTRIBUTION CHANNEL
TABLE 64.HOLLE BABY FOOD AG: COMPANY SNAPSHOT
TABLE 65.HOLLE BABY FOOD AG: PRODUCT PORTFOLIO
TABLE 66.HOLLE BABY FOOD AG: DISTRIBUTION CHANNEL
TABLE 67.KABRITA USA: COMPANY SNAPSHOT
TABLE 68.KABRITA USA: PRODUCT PORTFOLIO
TABLE 69.KABRITA USA: DISTRIBUTION CHANNEL
TABLE 70.NATURE’S ONE, LLC : COMPANY SNAPSHOT
TABLE 71.NATURE’S ONE, LLC: PRODUCT PORTFOLIO
TABLE 72.NATURE’S ONE, LLC: DISTRIBUTION CHANNEL
TABLE 73.NESTLE S.A: COMPANY SNAPSHOT
TABLE 74.NESTLE S.A: OPERATING SEGMENTS
TABLE 75.NESTLE S.A: PRODUCT PORTFOLIO
TABLE 76.NESTLE S.A: DISTRIBUTION CHANNEL
TABLE 77.NESTLE S.A: NET SALES, 2017–2019 ($MILLION)
TABLE 78.RECKITT BENCKISER GROUP PLC.: COMPANY SNAPSHOT
TABLE 79.RECKITT BENCKISER GROUP PLC: OPERATING SEGMENTS
TABLE 80.RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
TABLE 81.RECKITT BENCKISER GROUP PLC: DISTRIBUTION CHANNEL
TABLE 82.RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 83.RECKITT BENCKISER GROUP PLC.: NET SALES, 2017–2019 ($MILLION)
TABLE 84.THE HAIN CELESTIAL GROUP, INC.: COMPANY SNAPSHOT
TABLE 85.THE HAIN CELESTIAL GROUP, INC: PRODUCT PORTFOLIO
TABLE 86.THE HAIN CELESTIAL GROUP, INC: DISTRIBUTION CHANNEL
TABLE 87.THE HAIN CELESTIAL GROUP, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 01.U.S. BABY INFANT FORMULA MARKET VALUE, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 02.U.S. BABY INFANT FORMULA MARKET VOLUME, BY PRODUCT TYPE, 2019–2027 (KILOTON)
TABLE 03.U.S. BABY INFANT MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 04.U.S. BABY INFANT MILK MARKET VOLUME, 2019–2027 (KILOTON)
TABLE 05.U.S. FOLLOW-ON MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 06.U.S. FOLLOW-ON MILK MARKET VOLUME , 2019–2027 (KILOTON)
TABLE 07.U.S. SPECIALTY BABY MILK MARKET VALUE, 2019–2027 ($MILLION)
TABLE 08.U.S. SPECIALTY BABY MILK MARKET VOLUME, 2019–2027 (KILOTON)
TABLE 09.U.S. BABY INFANT FORMULA MARKET VALUE, BY POINT OF SALE, 2019–2027 ($MILLION)
TABLE 10.U.S. GROWING-UP MILK MARKET VALUE , 2019–2027 ($MILLION)
TABLE 11.U.S. GROWING-UP MILK MARKET VOLUME , 2019–2027 (KILOTON)
TABLE 12.U.S. BABY INFANT FORMULA MARKET VALUE, BY INGREDIENT, 2019–2027 ($MILLION)
TABLE 13.U.S. BABY INFANT FORMULA MARKET VALUE FOR CARBOHYDRATE, 2019–2027 ($MILLION)
TABLE 14.U.S. BABY INFANT FORMULA MARKET VALUE FOR FAT, 2019–2027 ($MILLION)
TABLE 15.U.S. BABY INFANT FORMULA MARKET VALUE FOR PROTEIN, 2019–2027 ($MILLION)
TABLE 16.U.S. BABY INFANT FORMULA MARKET VALUE FOR MINERALS, 2019–2027 ($MILLION)
TABLE 17.U.S. BABY INFANT FORMULA MARKET VALUE FOR VITAMINS, 2019–2027 ($MILLION)
TABLE 18.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2019–2027 ($MILLION)
TABLE 19.U.S. BABY INFANT FORMULA MARKET VALUE, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 20.U.S. BABY INFANT FORMULA MARKET VALUE FOR HYPERMARKET, 2019–2027 ($MILLION)
TABLE 21.U.S. BABY INFANT FORMULA MARKET VALUE FOR SUPERMARKET, 2019–2027 ($MILLION)
TABLE 22.U.S. BABY INFANT FORMULA MARKET VALUE FOR PHARMACY/MEDICAL STORES, 2019–2027 ($MILLION)
TABLE 23.U.S. BABY INFANT FORMULA MARKET VALUE FOR SPECIALTY STORES, 2019–2027 ($MILLION)
TABLE 24.U.S. BABY INFANT FORMULA MARKET VALUE FOR HARD DISCOUNTER STORES, 2019–2027 ($MILLION)
TABLE 25.U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2019–2027 ($MILLION)
TABLE 26.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 27.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 28.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 29.ABBOTT LABORATORIES: DISTRIBUTION CHANNEL
TABLE 30.ABBOTT LABORATORIES: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 31.ABBOTT LABORATORIES: NET SALES, 2017–2019 ($MILLION)
TABLE 32.ARLA FOODS AMBA: COMPANY SNAPSHOT
TABLE 33.ARLA FOODS AMBA: OPERATING SEGMENTS
TABLE 34.ARLA FOODS AMBA: PRODUCT PORTFOLIO
TABLE 35.ARLA FOODS AMBA: DISTRIBUTION CHANNEL
TABLE 36.ARLA FOODS AMBA: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 37.ARLA FOODS: NET SALES, 2017–2019 ($MILLION)
TABLE 38.BOBBIE: COMPANY SNAPSHOT
TABLE 39.BOBBIE: PRODUCT PORTFOLIO
TABLE 40.BOBBIE: DISTRIBUTION CHANNEL
TABLE 41.CAMPBELL SOUP COMPANY: COMPANY SNAPSHOT
TABLE 42.CAMPBELL SOUP COMPANY: OPERATING SEGMENTS
TABLE 43.CAMPBELL SOUP COMPANY: PRODUCT PORTFOLIO
TABLE 44.CAMPBELL SOUP COMPANY: DISTRIBUTION CHANNEL
TABLE 45.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 46.CAMPBELL SOUP COMPANY: NET SALES, 2017–2019 ($MILLION)
TABLE 47.DANA DAIRY GROUP LTD.: COMPANY SNAPSHOT
TABLE 48.DANA DAIRY GROUP LTD: PRODUCT PORTFOLIO
TABLE 49.DANA DAIRY GROUP LTD: DISTRIBUTION CHANNEL
TABLE 50.DANONE SA: COMPANY SNAPSHOT
TABLE 51.DANONE SA: OPERATING SEGMENTS
TABLE 52.DANONE SA: PRODUCT PORTFOLIO
TABLE 53.DANONE SA: DISTRIBUTION CHANNEL
TABLE 54.DANONE SA: NET SALES, 2017–2019 ($MILLION)
TABLE 55.D-SIGNSTORE: COMPANY SNAPSHOT
TABLE 56.D-SIGNSTORE: PRODUCT PORTFOLIO
TABLE 57.D-SIGNSTORE: DISTRIBUTION CHANNEL
TABLE 58.ELSE NUTRITION HOLDINGS INC: COMPANY SNAPSHOT
TABLE 59.ELSE NUTRITION HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 60.ELSE NUTRITION HOLDINGS INC: DISTRIBUTION CHANNEL
TABLE 61.HIPP GMBH & CO. VERTRIEB KG: COMPANY SNAPSHOT
TABLE 62.HIPP GMBH & CO. VERTRIEB KG: PRODUCT PORTFOLIO
TABLE 63.HIPP GMBH & CO. VERTRIEB KG: DISTRIBUTION CHANNEL
TABLE 64.HOLLE BABY FOOD AG: COMPANY SNAPSHOT
TABLE 65.HOLLE BABY FOOD AG: PRODUCT PORTFOLIO
TABLE 66.HOLLE BABY FOOD AG: DISTRIBUTION CHANNEL
TABLE 67.KABRITA USA: COMPANY SNAPSHOT
TABLE 68.KABRITA USA: PRODUCT PORTFOLIO
TABLE 69.KABRITA USA: DISTRIBUTION CHANNEL
TABLE 70.NATURE’S ONE, LLC : COMPANY SNAPSHOT
TABLE 71.NATURE’S ONE, LLC: PRODUCT PORTFOLIO
TABLE 72.NATURE’S ONE, LLC: DISTRIBUTION CHANNEL
TABLE 73.NESTLE S.A: COMPANY SNAPSHOT
TABLE 74.NESTLE S.A: OPERATING SEGMENTS
TABLE 75.NESTLE S.A: PRODUCT PORTFOLIO
TABLE 76.NESTLE S.A: DISTRIBUTION CHANNEL
TABLE 77.NESTLE S.A: NET SALES, 2017–2019 ($MILLION)
TABLE 78.RECKITT BENCKISER GROUP PLC.: COMPANY SNAPSHOT
TABLE 79.RECKITT BENCKISER GROUP PLC: OPERATING SEGMENTS
TABLE 80.RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
TABLE 81.RECKITT BENCKISER GROUP PLC: DISTRIBUTION CHANNEL
TABLE 82.RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2017–2019 ($MILLION)
TABLE 83.RECKITT BENCKISER GROUP PLC.: NET SALES, 2017–2019 ($MILLION)
TABLE 84.THE HAIN CELESTIAL GROUP, INC.: COMPANY SNAPSHOT
TABLE 85.THE HAIN CELESTIAL GROUP, INC: PRODUCT PORTFOLIO
TABLE 86.THE HAIN CELESTIAL GROUP, INC: DISTRIBUTION CHANNEL
TABLE 87.THE HAIN CELESTIAL GROUP, INC.: NET SALES, 2018–2020 ($MILLION)
LIST OF FIGURES
FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.U.S. BABY INFANT FORMULA MARKET SNAPSHOT, 2021–2027
FIGURE 03.TOP INVESTMENT POCKETS, 2019
FIGURE 04.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05.LOW BARGAINING POWER OF BUYERS
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 07.LOW THREAT OF SUBSTITUTES
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.MARKET DYNAMIC ANALYSIS
FIGURE 10.U.S. BABY INFANT FORMULA MARKET SHARE, BY PRODUCT TYPE, 2019 (%)
FIGURE 11.U.S. BABY INFANT FORMULA MARKET SHARE, BY INGRIDIENT, 2019 (%)
FIGURE 12.U.S. BABY INFANT FORMULA MARKET SHARE, BY DISTRIBUTION CHANNEL, 2019 (%)
FIGURE 13.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 14.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 15.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 16.PRODUCT MAPPING OF TOP 15 KEY PLAYERS
FIGURE 17.COMPETITIVE DASHBOARD OF TOP 15 KEY PLAYERS
FIGURE 18.COMPETITIVE HEATMAP OF TOP 15 KEY PLAYERS
FIGURE 19.ABBOTT LABORATORIES: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 20.ABBOTT LABORATORIES: NET SALES, 2017–2019 ($MILLION)
FIGURE 21.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 22.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 23.ARLA FOODS AMBA: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 24.ARLA FOODS AMBA: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.ARLA FOODS AMBA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 26.ARLA FOODS AMBA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 27.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 28.CAMPBELL SOUP COMPANY: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.CAMPBELL SOUP COMPANY: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 30.CAMPBELL SOUP COMPANY: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 31.DANONE SA: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.DANONE SA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 33.DANONE SA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 34.NESTLE S.A: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.NESTLE S.A: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36.NESTLE S.A: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37.RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 38.RECKITT BENCKISER GROUP PLC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.RECKITT BENCKISER GROUP PLC. REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.RECKITT BENCKISER GROUP PLC. REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.THE HAIN CELESTIAL GROUP, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.THE HAIN CELESTIAL GROUP, INC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.U.S. BABY INFANT FORMULA MARKET SNAPSHOT, 2021–2027
FIGURE 03.TOP INVESTMENT POCKETS, 2019
FIGURE 04.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05.LOW BARGAINING POWER OF BUYERS
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 07.LOW THREAT OF SUBSTITUTES
FIGURE 08.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09.MARKET DYNAMIC ANALYSIS
FIGURE 10.U.S. BABY INFANT FORMULA MARKET SHARE, BY PRODUCT TYPE, 2019 (%)
FIGURE 11.U.S. BABY INFANT FORMULA MARKET SHARE, BY INGRIDIENT, 2019 (%)
FIGURE 12.U.S. BABY INFANT FORMULA MARKET SHARE, BY DISTRIBUTION CHANNEL, 2019 (%)
FIGURE 13.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 14.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 15.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 16.PRODUCT MAPPING OF TOP 15 KEY PLAYERS
FIGURE 17.COMPETITIVE DASHBOARD OF TOP 15 KEY PLAYERS
FIGURE 18.COMPETITIVE HEATMAP OF TOP 15 KEY PLAYERS
FIGURE 19.ABBOTT LABORATORIES: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 20.ABBOTT LABORATORIES: NET SALES, 2017–2019 ($MILLION)
FIGURE 21.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 22.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 23.ARLA FOODS AMBA: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 24.ARLA FOODS AMBA: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.ARLA FOODS AMBA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 26.ARLA FOODS AMBA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 27.CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 28.CAMPBELL SOUP COMPANY: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.CAMPBELL SOUP COMPANY: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 30.CAMPBELL SOUP COMPANY: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 31.DANONE SA: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.DANONE SA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 33.DANONE SA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 34.NESTLE S.A: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.NESTLE S.A: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36.NESTLE S.A: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37.RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2017–2019 ($MILLION)
FIGURE 38.RECKITT BENCKISER GROUP PLC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.RECKITT BENCKISER GROUP PLC. REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.RECKITT BENCKISER GROUP PLC. REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.THE HAIN CELESTIAL GROUP, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.THE HAIN CELESTIAL GROUP, INC: REVENUE SHARE BY SEGMENT, 2020 (%)
